ArticleMolecular therapy. Nucleic acids2023

siRNA targeting ANGPTL3 stands in the spotlight for lipid-lowering therapy.

Bo Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.